GW406381X: Clinical Trials

3 trials of GW406381X, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 33Completed 3

Follow GW406381X: new trials by email Literature Review of GW406381X trials Research Report on GW406381X

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
COX-2 Inhibitor Study In Patients With Rheumatoid Arthritis
GW406381 - Arthritis, Rheumatoid
Phase 3CompletedGlaxoSmithKline22082005-06-012017-03-14
Evaluation of GW406381 in Treating Adults With Osteoarthritis Of The Knee
GW406381 - Osteoarthritis, Knee
Phase 3CompletedGlaxoSmithKline13402005-05-012017-01-19
Dental Pain (Following Third Molar Tooth Extraction) Study
GW406381 - Dental Pain, Surgery, Dental
Phase 3CompletedGlaxoSmithKline3002004-12-012017-01-19

Conditions studied

Arthritis, Rheumatoid (1)  ·  Osteoarthritis, Knee (1)  ·  Toothache (1)

Sponsors

GlaxoSmithKline (3)

Countries

Denmark (2)  ·  Netherlands (2)  ·  Norway (2)  ·  South Korea (2)  ·  Spain (2)  ·  United States (2)  ·  Argentina (1)  ·  Austria (1)  ·  Belgium (1)  ·  Bulgaria (1)  ·  Canada (1)  ·  Chile (1)  ·  Costa Rica (1)  ·  Finland (1)  ·  France (1)